SG/PUT/AMGEN/250/0.1/21.06.24 | Market Closed - Deutsche Boerse AG 01:19:01 01/06/2024 am IST | ||
| 0.001 EUR | -.--% |
|
| 3 months | -99.80% | ||
| 6 months | -99.90% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 31/24/31 | 0.001 | -.--% |
| 30/24/30 | 0.001 | -.--% |
| 29/24/29 | 0.001 | -.--% |
| 28/24/28 | 0.001 | -.--% |
| 27/24/27 | 0.001 | -.--% |
Delayed Quote Deutsche Boerse AG
Last update May 01, 2024 at 01:19 am IST
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SQ6K8Q |
| ISIN | DE000SQ6K8Q3 |
| Date issued | 20/12/2022 |
| Strike | 250 $ |
| Maturity | 21/06/2024 (19 Days) |
| Parity | 10 : 1 |
| Emission price | 2.25 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.91 € |
|---|---|
| Lowest since issue | 0.001 € |
| Delta | -0.03x |
| Omega | 23.21 |
| Premium | 18.36x |
| Gearing | 854.23x |
| Moneyness | 0.8175 |
| Difference Strike | -55.8 $ |
| Difference Strike % | -22.32% |
| Spread | 0.064 € |
| Spread % | 98.46% |
| Intrinsic value | 0.000000 |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305.8
USD
Average target price
316.3
USD
Spread / Average Target
+3.41%
- Stock Market
- Warrants
- Warrant
